Large molecules on QPatch: IgG antibodies against α-cobratoxin as novel antivenom


Application Report


Kim Boddum, Sophion Bioscience, Line Ledsgaard, Tropical Pharmacology lab, DTU



To determine if engineered IgG anti-α-cobratoxin antibodies would prevent the blocking of the nicotinic acetylcholine receptor, a protocol was set up using QPatch II. Here we show that:

  • QPatch II is well suited for efficiently characterizing both peptide toxins and antibody function.
  • Current induced by adding acetylcholine could be abolished completely using α-cobratoxin, and that this effect could be reversed by preincubating the toxin with different IgGs before injection.
  • Prevention of current inhibition by the IgGs was dose-dependent, and the potency of different IgGs could be determined using this method.
  • Increased affinity between the IgGs and α-cobratoxin resulted in higher neutralization potency.

Keywords: Large molecules

Go to journal

Get in Touch

We strive to provide the best for our customers, and we are always ready to help. Please let us know if you have a question for us.

Follow us